Madhavan Balachandran
Director/Board Member presso UNIQURE N.V.
Patrimonio netto: 3 M $ in data 31/03/2024
Profilo
Attualmente, Madhavan Balachandran occupa la posizione di direttore operativo di Brentwood Press & Publishing Co. e di direttore operativo di Nutcracker Therapeutics, Inc. Il sig. Balachandran è anche nel consiglio di amministrazione di altre 5 società. In passato il sig. Balachandran ha ricoperto la posizione di amministratore delegato e direttore di ADRx, Inc., vicepresidente esecutivo di Amgen, Inc., vicepresidente di Glaxo Wellcome, Inc., direttore del Battelle Memorial Institute e vicepresidente della Puerto Rico USA Citizenship Foundation. Ha ricevuto un MBA dalla East Carolina University, una laurea presso l'Indian Institute of Technology Bombay e una laurea presso la State University of New York a Buffalo.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
07/03/2024 | 58 103 ( 0.02% ) | 2 M $ | 31/03/2024 | |
CATALENT INC
0.01% | 04/12/2023 | 20 448 ( 0.01% ) | 1 M $ | 31/03/2024 |
UNIQURE N.V.
0.04% | 15/09/2023 | 17 290 ( 0.04% ) | 89 908 $ | 31/03/2024 |
Posizioni attive di Madhavan Balachandran
Società | Posizione | Inizio |
---|---|---|
UNIQURE N.V. | Director/Board Member | 14/09/2017 |
STEVANATO GROUP S.P.A. | Director/Board Member | 01/09/2018 |
Fortuna Fix, Inc.
Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | Director/Board Member | 01/06/2018 |
Nutcracker Therapeutics, Inc.
Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Nutcracker Therapeutics, Inc. provides Biotechnology services. It offers push button operation, rapid cycle times and delivery vehicles. The company was founded by Igor Khandros and Benjamin Eldridge in 2018 and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 23/09/2020 |
Brentwood Press & Publishing Co.
Brentwood Press & Publishing Co. Publishing: NewspapersConsumer Services Brentwood Press & Publishing Co. publishes newspapers. It offers print and digital media, website design, social media training and consultation. The company was founded by James Chamoures and is headquartered in Brentwood, CA. | Chief Operating Officer | 23/09/2020 |
A2 Biotherapeutics, Inc.
A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Director/Board Member | - |
Precedenti posizioni note di Madhavan Balachandran
Società | Posizione | Fine |
---|---|---|
CATALENT, INC. | Director/Board Member | 25/01/2024 |
ADRx, Inc.
ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Chief Executive Officer | 01/10/2020 |
AMGEN INC. | Chief Operating Officer | 01/01/2001 |
░░░░░░ ░░░░ ░░░ ░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Madhavan Balachandran
East Carolina University | Masters Business Admin |
State University of New York at Buffalo | Graduate Degree |
Indian Institute of Technology Bombay | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
AMGEN INC. | Health Technology |
STEVANATO GROUP S.P.A. | Health Technology |
UNIQURE N.V. | Health Technology |
CATALENT, INC. | Health Technology |
Aziende private | 8 |
---|---|
Battelle Memorial Institute
Battelle Memorial Institute Miscellaneous Commercial ServicesCommercial Services Battelle Memorial Institute operates as a science and technology development company. It offers services for government and commercial. The company was founded by Gordon Battelle in 1929 and is headquartered in Columbus, OH. | Commercial Services |
Brentwood Press & Publishing Co.
Brentwood Press & Publishing Co. Publishing: NewspapersConsumer Services Brentwood Press & Publishing Co. publishes newspapers. It offers print and digital media, website design, social media training and consultation. The company was founded by James Chamoures and is headquartered in Brentwood, CA. | Consumer Services |
Glaxo Wellcome, Inc. | Health Technology |
Puerto Rico USA Citizenship Foundation | |
Fortuna Fix, Inc.
Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | Health Technology |
A2 Biotherapeutics, Inc.
A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Commercial Services |
Nutcracker Therapeutics, Inc.
Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Nutcracker Therapeutics, Inc. provides Biotechnology services. It offers push button operation, rapid cycle times and delivery vehicles. The company was founded by Igor Khandros and Benjamin Eldridge in 2018 and is headquartered in Emeryville, CA. | Technology Services |
ADRx, Inc.
ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Health Technology |
- Borsa valori
- Insiders
- Madhavan Balachandran